Follow
Cheng Zu
Cheng Zu
the First Affiliated Hospital, Zhejiang University School of Medicine
Verified email at zju.edu.cn
Title
Cited by
Cited by
Year
BCMA CAR-T therapy is safe and effective for refractory/relapsed multiple myeloma with central nervous system involvement
Y Wang, C Zu, X Teng, L Yang, M Zhang, R Hong, H Zhao, J Cui, H Xu, ...
Journal of Immunotherapy 45 (1), 25-34, 2022
92022
Cytomegalovirus retinitis and retinal detachment following chimeric antigen receptor T cell therapy for relapsed/refractory multiple myeloma
C Zu, Y Xu, Y Wang, M Zhang, H Zhao, X Fang, H Huang, Y Hu
Current Oncology 29 (2), 490-496, 2022
82022
The system can't perform the operation now. Try again later.
Articles 1–2